Page last updated: 2024-10-17

choline and Depression, Involutional

choline has been researched along with Depression, Involutional in 51 studies

Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.

Research Excerpts

ExcerptRelevanceReference
"Discontinuation syndrome is associated with a rostral anterior cingulate Cho/Cre metabolite ratio decrease that may reflect dynamics of rostral anterior cingulate function."6.71Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. ( Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA, 2003)
"Discontinuation syndrome is associated with a rostral anterior cingulate Cho/Cre metabolite ratio decrease that may reflect dynamics of rostral anterior cingulate function."2.71Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. ( Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA, 2003)
"Smaller hippocampal volumes in major depressive disorder (MDD) have been linked with earlier onset, previous recurrences and treatment refractoriness."1.39Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. ( Álvarez, E; de Diego-Adeliño, J; Gómez-Ansón, B; López-Moruelo, O; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D; Serra-Blasco, M; Vives, Y, 2013)
"Seventy-five elderly patients with major depressive disorder in remission underwent assessment of insight using the Mood Disorders Insight Scale (MDIS), including awareness, attribution, and need for treatment."1.36Brain proton magnetic resonance spectroscopic study of insight among elders with late-life depression in remission. ( Chang, HC; Chen, CS; Ko, CH; Kuo, YT; Li, CW; Lin, HF; Liu, GC; Yeh, YC; Yen, CF, 2010)
"Patients with late-life major depressive disorder had a significantly lower NAA/creatine ratio in the left frontal white matter, and higher Cho/creatine and myo-inositol/creatine ratios in the left basal ganglia when compared with the control subjects."1.35Proton magnetic resonance spectroscopy of late-life major depressive disorder. ( Chen, CS; Chiang, IC; Hsieh, TJ; Kuo, YT; Li, CW; Lin, HF; Lin, WC; Liu, GC; Lu, CY, 2009)
"The neural underpinnings of major depressive disorder (MDD) are unknown but there is evidence for structural alteration in the hippocampus that may become more pronounced over the course of illness."1.35Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. ( Hall, GB; MacQueen, GM; Milne, A; Soreni, N; Yucel, K, 2009)
"Patients with type 2 diabetes and major depression (n=20) were scanned along with patients with diabetes alone (n=24) and healthy controls (n=21) on a 1."1.34Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. ( Ajilore, O; Binesh, N; Darwin, C; Haroon, E; Kumar, A; Kumaran, S; Miller, J; Mintz, J; Thomas, MA, 2007)
"Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor that has shown efficacy in the treatment of Parkinson's disease."1.30Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. ( Alpert, JE; Bottiglieri, T; Fava, M; Kolsky, AR; Magni, G; Moore, C; Moroz, G; Nierenberg, AA; Renshaw, P; Rosenbaum, JF; Spillmann, M, 1999)

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (1.96)18.2507
2000's24 (47.06)29.6817
2010's19 (37.25)24.3611
2020's7 (13.73)2.80

Authors

AuthorsStudies
Lv, S2
Zhong, S7
Zhang, S1
Lai, S5
Wang, Y9
Zhao, H3
Zhang, Y3
Luo, Y2
Yan, S2
Ran, H2
Chen, P4
Chen, G3
Jia, Y9
Wu, W1
He, J2
Zhu, Y3
Qi, Z1
Song, Z2
Hu, Y1
Miao, H2
Huang, X2
Lu, X2
Liu, X1
Ye, K1
Duan, M1
Song, K1
Güleş, E1
Iosifescu, DV1
Tural, Ü1
Kahl, KG1
Atalay, S1
Maudsley, AA1
Sheriff, S1
Cummings, A1
Frieling, H1
Schmitz, B1
Lanfermann, H1
Ding, XQ1
Badamasi, IM1
Maulidiani, M1
Lye, MS1
Ibrahim, N1
Shaari, K1
Stanslas, J1
Freed, RD1
Hollenhorst, CN1
Weiduschat, N1
Mao, X2
Kang, G2
Shungu, DC2
Gabbay, V3
Shan, Y1
Li, X1
Chen, J1
Lu, Q1
Zhang, L1
Li, Z1
Riley, CA1
Renshaw, PF3
Tang, Y1
Zhang, X2
Sheng, J1
Zhang, J3
Xu, J1
Wang, J2
Zhang, T1
Tong, S1
Ning, L1
Liu, M1
Li, Y1
de Diego-Adeliño, J2
Portella, MJ2
Gómez-Ansón, B2
López-Moruelo, O1
Serra-Blasco, M1
Vives, Y2
Puigdemont, D2
Pérez-Egea, R2
Álvarez, E1
Pérez, V2
Tae, WS1
Kim, SS1
Lee, KU1
Nam, EC1
Koh, SH1
Chen, LP1
Dai, HY1
Dai, ZZ1
Xu, CT2
Wu, RH2
Shi, XF1
Forrest, LN1
Kuykendall, MD1
Prescot, AP1
Sung, YH1
Huber, RS1
Hellem, TL1
Jeong, EK1
Kondo, DG1
Zhao, G1
Xiang, Q1
Ling, X3
Liu, S4
Huang, L4
Liu, T1
Liao, X1
Bradley, KA1
Case, JA1
Yang, XR1
Langevin, LM1
Jaworska, N1
Kirton, A1
Lebel, RM1
Harris, AD1
Jasaui, Y1
Wilkes, TC1
Sembo, M1
Swansburg, R1
MacMaster, FP3
Tan, HZ1
Li, H1
Liu, CF1
Guan, JT1
Guo, XB1
Wen, CH1
Ou, SM1
Zhang, YN1
Shen, ZW1
Wang, XQ1
Murck, H1
Schubert, MI1
Schmid, D1
Schüssler, P1
Steiger, A1
Auer, DP2
Moore, GJ3
Russell, A3
Mirza, Y2
Taormina, SP1
Buhagiar, C1
Rosenberg, DR3
Block, W1
Träber, F1
von Widdern, O1
Metten, M1
Schild, H1
Maier, W1
Zobel, A1
Jessen, F1
Venkatraman, TN1
Krishnan, RR1
Steffens, DC1
Song, AW1
Taylor, WD1
Chen, CS2
Chiang, IC1
Li, CW2
Lin, WC1
Lu, CY1
Hsieh, TJ1
Liu, GC2
Lin, HF2
Kuo, YT2
Milne, A1
MacQueen, GM1
Yucel, K1
Soreni, N1
Hall, GB1
Kaymak, SU1
Demir, B1
Oğuz, KK1
Sentürk, S1
Uluğ, B1
Rao, V1
Munro, CA1
Rosenberg, P1
Ward, J1
Bertrand, M1
Degoankar, M1
Horská, A1
Pham, D1
Yousem, DM1
Barker, PB1
Ko, CH1
Yeh, YC1
Chang, HC1
Yen, CF1
Morgan-Ferrando, R1
Ruscalleda, J1
Xu, G2
Narr, KL1
Woods, RP1
Phillips, OR1
Alger, JR1
Espinoza, RT1
Chen, X1
Obergriesser, T1
Ende, G1
Braus, DF1
Henn, FA1
Kaufman, MJ1
Henry, ME1
Frederick, Bd1
Hennen, J1
Villafuerte, RA1
Stoddard, EP1
Schmidt, ME1
Cohen, BM1
Vythilingam, M1
Charles, HC1
Tupler, LA1
Blitchington, T1
Kelly, L1
Krishnan, KR1
Smith, EA1
Lorch, E1
Banerjee, SP2
Rose, M2
Ivey, J2
Bhandari, R2
Wood, SJ1
Berger, G1
Velakoulis, D1
Phillips, LJ1
McGorry, PD1
Yung, AR1
Desmond, P1
Pantelis, C1
Blasi, G1
Bertolino, A1
Brudaglio, F1
Sciota, D1
Altamura, M1
Antonucci, N1
Scarabino, T1
Weinberger, DR1
Nardini, M1
Tang, J1
Smith, JM1
Boyd, C1
Caetano, SC1
Fonseca, M1
Olvera, RL1
Nicoletti, M1
Hatch, JP1
Stanley, JA1
Hunter, K1
Lafer, B1
Pliszka, SR1
Soares, JC1
Coupland, NJ1
Ogilvie, CJ1
Hegadoren, KM1
Seres, P1
Hanstock, CC1
Allen, PS1
Yildiz-Yesiloglu, A1
Ankerst, DP1
Ajilore, O1
Haroon, E1
Kumaran, S1
Darwin, C1
Binesh, N1
Mintz, J2
Miller, J1
Thomas, MA1
Kumar, A2
Holtzmann, J1
Polosan, M1
Baro, P1
Bougerol, T1
Hess, DA1
Babb, JS1
Klein, RG1
Gonen, O1
Fava, M1
Rosenbaum, JF1
Kolsky, AR1
Alpert, JE1
Nierenberg, AA1
Spillmann, M1
Moore, C1
Renshaw, P1
Bottiglieri, T1
Moroz, G1
Magni, G1
Pütz, B1
Kraft, E1
Lipinski, B1
Schill, J1
Holsboer, F1
Murata, T1
Kimura, H1
Omori, M1
Kado, H1
Kosaka, H1
Iidaka, T1
Itoh, H1
Wada, Y1
Kusumakar, V1
Gates, L1
Sparkes, SJ1
Khan, SC1
Thomas, A1
Lavretsky, H1
Yue, K1
Huda, A1
Curran, J1
Venkatraman, T1
Estanol, L1
Mega, M1
Toga, A1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070]68 participants (Actual)Interventional2007-08-31Completed
Pharmacogenetics and Neuroimaging in Major Depressive Disorder (PAN-D)[NCT01568684]Phase 10 participants (Actual)Interventional2012-03-12Withdrawn
An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist With Neurotrophic Properties in Major Depression[NCT00040261]Phase 3112 participants Interventional2002-06-30Completed
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression[NCT00054704]Phase 219 participants (Actual)Interventional2003-02-28Terminated (stopped due to Placebo was better than active drug.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Montgomery-Asberg Depression Rating Scale

The Montgomery-Asberg Depression Rating Scale (MADRS) is a clinician-rated assessment of depression symptoms. Patients were rated weekly on 10 symptoms on a scale of 0 to 6 for each item, where 0 indicated no symptoms and 6 indicated the highest severity of that symptom. Total scores range from 0 to 60, where a moderate severity of depression would be present with a score of at least 20. (NCT00054704)
Timeframe: 8 weeks

InterventionUnits on a scale (Least Squares Mean)
Riluzole29.551
Placebo23.723

Reviews

3 reviews available for choline and Depression, Involutional

ArticleYear
Brain choline in major depression: A review of the literature.
    Psychiatry research. Neuroimaging, 2018, 01-30, Volume: 271

    Topics: Brain; Choline; Cross-Sectional Studies; Depressive Disorder, Major; Electroconvulsive Therapy; Huma

2018
Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Psychiatry research, 2006, Jun-30, Volume: 147, Issue:1

    Topics: Aspartic Acid; Brain; Choline; Creatine; Depressive Disorder, Major; gamma-Aminobutyric Acid; Glutam

2006
[ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect].
    L'Encephale, 2007, Volume: 33, Issue:4 Pt 1

    Topics: Antidepressive Agents; Aspartic Acid; Brain; Brain-Derived Neurotrophic Factor; Choline; Depressive

2007

Trials

6 trials available for choline and Depression, Involutional

ArticleYear
Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.
    Psychiatry and clinical neurosciences, 2014, Volume: 68, Issue:5

    Topics: Adolescent; Adult; Antidepressive Agents; Aspartic Acid; Cerebellum; Choline; Depressive Disorder, M

2014
The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.
    Journal of psychiatric research, 2009, Volume: 43, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Choline; Creatine; Depressive Disorder, Ma

2009
Glutamate normalization with ECT treatment response in major depression.
    Molecular psychiatry, 2013, Volume: 18, Issue:3

    Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Depressive Disorder, Major; Electroconvulsive T

2013
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Antidepressive Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; De

2012
Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study.
    Biological psychiatry, 2003, Sep-01, Volume: 54, Issue:5

    Topics: Adult; Brain Mapping; Choline; Depressive Disorder, Major; Female; Fluoxetine; Gyrus Cinguli; Humans

2003
Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients.
    Neuroscience letters, 2005, Aug-26, Volume: 384, Issue:3

    Topics: Adolescent; Child; Choline; Depressive Disorder, Major; Female; Glutamine; Humans; Inositol; Magneti

2005

Other Studies

42 other studies available for choline and Depression, Involutional

ArticleYear
Correlations between facial emotion processing and biochemical abnormalities in untreated adolescent patients with major depressive disorder: A proton magnetic resonance spectroscopy study.
    Journal of affective disorders, 2022, 01-01, Volume: 296

    Topics: Adolescent; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Emotions; Humans; Prefront

2022
Associations between executive function impairment and biochemical abnormalities in depressed adolescents with non-suicidal self-injury.
    Journal of affective disorders, 2022, 02-01, Volume: 298, Issue:Pt A

    Topics: Adolescent; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Executive Function; Humans

2022
Childhood trauma history is linked to abnormal brain metabolism of non-medicated adult patients with major depressive disorder.
    Journal of affective disorders, 2022, 04-01, Volume: 302

    Topics: Adult; Adverse Childhood Experiences; Aspartic Acid; Brain; Child, Preschool; Choline; Creatine; Cro

2022
Cognitive dysfunction and neurometabolic alternations in major depressive disorder with gastrointestinal symptoms.
    Journal of affective disorders, 2023, 02-01, Volume: 322

    Topics: Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Depressive Disorder, Major; Humans; Proton

2023
Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study.
    Neuropsychobiology, 2020, Volume: 79, Issue:3

    Topics: Adult; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Gyrus Cinguli; Humans;

2020
Altered neurometabolism in major depressive disorder: A whole brain
    Progress in neuro-psychopharmacology & biological psychiatry, 2020, 07-13, Volume: 101

    Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Depressive Disorder, Major; Energy Metabolism; Femal

2020
A Preliminary Nuclear Magnetic Resonance Metabolomics Study Identifies Metabolites that Could Serve as Diagnostic Markers of Major Depressive Disorder.
    Current neuropharmacology, 2022, Volume: 20, Issue:5

    Topics: Acetone; Alanine; Biomarkers; Choline; Creatinine; Depressive Disorder, Major; Fatty Acids; Glutamin

2022
A pilot study of cortical glutathione in youth with depression.
    Psychiatry research. Neuroimaging, 2017, Dec-30, Volume: 270

    Topics: Adolescent; Anhedonia; Aspartic Acid; Case-Control Studies; Child; Choline; Creatine; Depression; De

2017
Correlations between working memory impairment and neurometabolites of prefrontal cortex and lenticular nucleus in patients with major depressive disorder.
    Journal of affective disorders, 2018, Volume: 227

    Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Corpus Striatum; Creatine; Depressive Disorder,

2018
Elevated hippocampal choline level is associated with altered functional connectivity in females with major depressive disorder: A pilot study.
    Psychiatry research. Neuroimaging, 2018, 08-30, Volume: 278

    Topics: Adult; Brain; Brain Mapping; Choline; Depressive Disorder, Major; Female; Humans; Magnetic Resonance

2018
Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.
    Journal of psychiatry & neuroscience : JPN, 2013, Volume: 38, Issue:2

    Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Cost of Illness; Cross-Sectional Studies; Depre

2013
Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study.
    Acta radiologica (Stockholm, Sweden : 1987), 2014, Volume: 55, Issue:5

    Topics: Adult; Antidepressive Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectiona

2014
Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosis.
    Journal of affective disorders, 2014, Volume: 167

    Topics: Adolescent; Analysis of Variance; Bipolar Disorder; Choline; Creatine; Cross-Sectional Studies; Depr

2014
Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Journal of affective disorders, 2014, Volume: 168

    Topics: Adolescent; Adult; Aspartic Acid; Bipolar Disorder; Brain; Choline; Creatine; Depressive Disorder, M

2014
The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid hormone levels in first-episode patients with major depressive disorder.
    Journal of affective disorders, 2015, Jul-15, Volume: 180

    Topics: Adult; Aspartic Acid; Brain Chemistry; Choline; Creatine; Depressive Disorder, Major; Female; Hippoc

2015
Increased ventricular cerebrospinal fluid lactate in depressed adolescents.
    European psychiatry : the journal of the Association of European Psychiatrists, 2016, Volume: 32

    Topics: Adolescent; Aspartic Acid; Cerebral Ventricles; Cerebrospinal Fluid; Choline; Creatine; Depressive D

2016
Proton spectroscopy study of the dorsolateral prefrontal cortex in youth with familial depression.
    Psychiatry and clinical neurosciences, 2016, Volume: 70, Issue:7

    Topics: Adolescent; Adult; Choline; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Fe

2016
Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders.
    Scientific reports, 2016, 11-21, Volume: 6

    Topics: Adult; Aspartic Acid; Biomarkers; Bipolar Disorder; Case-Control Studies; Choline; Creatine; Depress

2016
Medial temporal N-acetyl-aspartate in pediatric major depression.
    Psychiatry research, 2008, Oct-30, Volume: 164, Issue:1

    Topics: Adolescent; Aspartic Acid; Child; Choline; Creatine; Depressive Disorder, Major; Female; Humans; Mal

2008
Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:3

    Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Depressive Disorder, Major; Female; gamma-Amino

2009
Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression.
    Psychiatry research, 2009, Apr-30, Volume: 172, Issue:1

    Topics: Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Energy Metabolism; Functional Laterali

2009
Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Psychiatry research, 2009, Jun-30, Volume: 172, Issue:3

    Topics: Aged; Aging; Aspartic Acid; Basal Ganglia; Biomarkers; Brain; Choline; Cognition; Creatine; Depressi

2009
Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study.
    NeuroImage, 2009, Aug-01, Volume: 47, Issue:1

    Topics: Adult; Analysis of Variance; Aspartic Acid; Choline; Depressive Disorder, Major; Female; Glutamic Ac

2009
Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:3

    Topics: Adult; Antidepressive Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; Depressive Dis

2009
Neuroanatomical correlates of depression in post traumatic brain injury: preliminary results of a pilot study.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Spring, Volume: 22, Issue:2

    Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Brain Injuries; Case-Control Studies; Choline; Cognition

2010
Brain proton magnetic resonance spectroscopic study of insight among elders with late-life depression in remission.
    Journal of affective disorders, 2010, Volume: 127, Issue:1-3

    Topics: Aged; Aspartic Acid; Awareness; Choline; Creatine; Depressive Disorder, Major; Dominance, Cerebral;

2010
Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients.
    Journal of psychiatric research, 2011, Volume: 45, Issue:4

    Topics: Adult; Age of Onset; Aspartic Acid; Choline; Chronic Disease; Depressive Disorder, Major; Disease Pr

2011
Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Journal of affective disorders, 2012, Volume: 136, Issue:3

    Topics: Adolescent; Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Choline; Creatine; Depressive Dis

2012
Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:7

    Topics: Aspartic Acid; Choline; Cognition Disorders; Creatine; Depressive Disorder, Major; Electroconvulsive

2003
Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study.
    Biological psychiatry, 2003, Oct-01, Volume: 54, Issue:7

    Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Brain Mapping; Choline; Creatine; Depressive Disorder,

2003
Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.
    Biological psychiatry, 2003, Dec-15, Volume: 54, Issue:12

    Topics: Adolescent; Analysis of Variance; Brain Chemistry; Brain Mapping; Case-Control Studies; Child; Choli

2003
Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Schizophrenia bulletin, 2003, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aspartic Acid; Bipolar Disorder; Brain Mapping; Choline; Creatine; Depressive Dis

2003
Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Psychiatry research, 2004, Jul-30, Volume: 131, Issue:2

    Topics: Adolescent; Adult; Aspartic Acid; Bipolar Disorder; Cerebral Cortex; Choline; Creatine; Depressive D

2004
Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:9

    Topics: Adolescent; Aspartic Acid; Child; Choline; Creatine; Depressive Disorder, Major; Female; Glutamic Ac

2004
Decreased prefrontal Myo-inositol in major depressive disorder.
    Biological psychiatry, 2005, Jun-15, Volume: 57, Issue:12

    Topics: Adult; Aspartic Acid; Brain Chemistry; Brain Mapping; Case-Control Studies; Choline; Creatine; Depre

2005
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Chemistry; Choline; Creatine; Depressive Disord

2007
Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.
    The American journal of psychiatry, 2007, Volume: 164, Issue:12

    Topics: Adolescent; Aspartic Acid; Caudate Nucleus; Choline; Cohort Studies; Creatine; Depressive Disorder,

2007
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:4

    Topics: Adult; Benzophenones; Catechol O-Methyltransferase Inhibitors; Caudate Nucleus; Choline; Depressive

1999
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
    Biological psychiatry, 2000, Feb-15, Volume: 47, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Frontal Lobe; Glu

2000
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
    Biological psychiatry, 2000, Feb-15, Volume: 47, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Frontal Lobe; Glu

2000
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
    Biological psychiatry, 2000, Feb-15, Volume: 47, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Frontal Lobe; Glu

2000
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
    Biological psychiatry, 2000, Feb-15, Volume: 47, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Frontal Lobe; Glu

2000
MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases.
    International journal of geriatric psychiatry, 2001, Volume: 16, Issue:12

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Creatine; Depressive Disorder, Major; Energy

2001
Left medial temporal cytosolic choline in early onset depression.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:10

    Topics: Adolescent; Amygdala; Aspartic Acid; Choline; Creatine; Cytosol; Depressive Disorder, Major; Dominan

2001
Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy.
    The American journal of psychiatry, 2002, Volume: 159, Issue:4

    Topics: Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Dominance, Cerebral; Energy Meta

2002